Whitney Brown
Pediatric Endocrinology · Columbia, SCNPI 1972681096
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $593, 5.6 times the $106 reported in 2019.
Across 70 payments — averaging $23.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$226
- Medtronic$165
- Kyowa Kirin, Inc.$139
- Sanofi-aventis U.S. LLC$100
- Ascendis Pharma Endocrinology Inc$92
- Pfizer$87
- plus $846 from 23 others
What the payments were for
- Food & beverage$1,655100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $226 |
| Medtronic(2 entities) | 4 | $165 |
| Kyowa Kirin, Inc. | 2 | $139 |
| Sanofi-aventis U.S. LLC | 3 | $100 |
| Ascendis Pharma Endocrinology Inc | 5 | $92 |
| Pfizer | 4 | $87 |
| Dexcom, Inc. | 4 | $84 |
| BETA Bionics, Inc. | 4 | $76 |
| Endo USA, Inc. | 3 | $74 |
| Novo Nordisk | 4 | $66 |
| Tandem Diabetes Care, Inc. | 4 | $64 |
| Abbott | 3 | $51 |
| Biomarin Pharmaceutical Inc. | 3 | $49 |
| Rhythm Pharmaceuticals, Inc. | 2 | $47 |
| Insulet Corporation | 2 | $39 |
| Soleno Therapeutics, Inc. | 1 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Endo Pharmaceuticals Inc. | 2 | $26 |
| Tolmar, Inc. | 1 | $24 |
| Sequel Med Tech, LLC | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Amphastar Pharmaceuticals, Inc. | 1 | $20 |
| BD | 1 | $19 |
| Eton Pharmaceuticals, Inc. | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Minimed 770G System$124
- CRYSVITA$121
How this compares
Too few pediatric endocrinology providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Columbia
- Alison LunsfordColumbia$13K
- Lisa KnightColumbia$3K
- Bhavana NaralaColumbia$1K
- Elaine AppersonGreenville$46K
- Tarina MendesSeneca$5K
- Deidre McSweeny-TysonFlorence$3K
- Ryan DyessGreenville$2K
- Katherine LewisGreenville$2K
- Melissa GargantaGreenville$925
- Remberto PauloCharleston$675
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.